Axsome Therapeutics AXSM Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Axsome Therapeutics's income tax?
- Axsome Therapeutics (AXSM) reported income tax of $0 in Q1 2026.
- What does income tax mean?
- The total amount of tax the company owes on its earnings.
- How do you interpret income tax?
- An increase typically correlates with higher taxable income, though it can also be influenced by changes in tax credits or deferred tax assets.
- How does income tax compare across companies?
- Varies significantly based on geographic footprint and the utilization of net operating loss carryforwards common in clinical-stage companies.